Amova Asset Management Americas Inc. Purchases 47,443 Shares of Schrodinger, Inc. $SDGR

Amova Asset Management Americas Inc. boosted its stake in Schrodinger, Inc. (NASDAQ:SDGR) by 1.8% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,638,935 shares of the company’s stock after purchasing an additional 47,443 shares during the period. Amova Asset Management Americas Inc. owned about 3.59% of Schrodinger worth $52,937,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SDGR. Massachusetts Financial Services Co. MA grew its holdings in Schrodinger by 38.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,072,433 shares of the company’s stock worth $41,573,000 after acquiring an additional 577,899 shares during the period. Capital Fund Management S.A. bought a new stake in shares of Schrodinger during the 2nd quarter valued at about $1,486,000. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Schrodinger by 24.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,554,569 shares of the company’s stock valued at $91,365,000 after purchasing an additional 904,619 shares in the last quarter. Nikko Asset Management Americas Inc. grew its stake in Schrodinger by 7.2% during the second quarter. Nikko Asset Management Americas Inc. now owns 2,591,492 shares of the company’s stock worth $52,089,000 after purchasing an additional 174,684 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new stake in Schrodinger in the third quarter worth approximately $1,732,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Schrodinger Trading Up 5.0%

Schrodinger stock opened at $13.12 on Thursday. The business’s 50 day simple moving average is $14.99 and its 200 day simple moving average is $17.68. Schrodinger, Inc. has a 12 month low of $11.11 and a 12 month high of $27.63. The company has a market cap of $966.55 million, a price-to-earnings ratio of -9.24 and a beta of 1.57.

Schrodinger (NASDAQ:SDGR) last issued its earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.57. The firm had revenue of $87.24 million for the quarter, compared to analyst estimates of $83.66 million. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The business’s revenue was up 4.7% on a year-over-year basis. During the same period in the previous year, the company posted ($0.24) earnings per share. As a group, equities research analysts forecast that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Analyst Ratings Changes

SDGR has been the subject of a number of research reports. KeyCorp reduced their price target on shares of Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a report on Thursday, January 8th. Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Bank of America raised Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research report on Monday, December 15th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Schrodinger in a report on Friday, January 9th. Finally, TD Cowen reissued a “buy” rating on shares of Schrodinger in a research note on Thursday, January 8th. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Schrodinger currently has an average rating of “Hold” and a consensus price target of $21.75.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.